HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival--4.

Abstract
In a randomized, placebo-controlled trial, the effects of treatment with fish oil (eicosapentaenoic acid, 1.08 g/day) and mustard oil (alpha-linolenic acid, 2.9 g/day) were compared for 1 year in the management of 122 patients (fish oil, group A), 120 patients (mustard oil, group B), and 118 patients (placebo, group C) with suspected acute myocardial infarction (AMI). Treatments were administered about (mean) 18 hours after the symptoms of AMI in all three groups. The extent of cardiac disease, rise in cardiac enzymes, and lipid peroxides were comparable among the groups at entry into the study. After 1 year total cardiac events were significantly less in the fish oil and mustard oil groups compared with the placebo group (24.5% and 28% vs. 34.7%, p < 0.01). Nonfatal infarctions were also significantly less in the fish oil and mustard oil groups compared with the placebo group (13.0% and 15.0% vs. 25.4%, p < 0.05). Total cardiac deaths showed no significant reduction in the mustard oil group; however, the fish oil group had significantly less cardiac deaths compared with the placebo group (11.4% vs. 22.0%, p < 0.05). Apart from the decrease in the cardiac event rate, the fish oil and mustard oil groups also showed a significant reduction in total cardiac arrhythmias, left ventricular enlargement, and angina pectoris compared with the placebo group. Reductions in blood lipoproteins in the two intervention groups were modest and do not appear to be the cause of the benefit in the two groups. Diene conjugates showed a significant reduction in the fish oil and mustard oil groups, indicating that a part of the benefit may be caused by the reduction in oxidative stress. The findings of this study suggest that fish oil and mustard oil, possibly due to the presence of n-3 fatty acids, may provide rapid protective effects in patients with AMI. However, a large study is necessary to confirm this suggestion.
AuthorsR B Singh, M A Niaz, J P Sharma, R Kumar, V Rastogi, M Moshiri
JournalCardiovascular drugs and therapy (Cardiovasc Drugs Ther) Vol. 11 Issue 3 Pg. 485-91 (Jul 1997) ISSN: 0920-3206 [Print] United States
PMID9310278 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Cholesterol, HDL
  • Drug Combinations
  • Fish Oils
  • Lipoproteins
  • Maxepa
  • Plant Extracts
  • Plant Oils
  • Triglycerides
  • Docosahexaenoic Acids
  • Eicosapentaenoic Acid
  • mustard oil
Topics
  • Adult
  • Aged
  • Angina Pectoris (complications)
  • Arrhythmias, Cardiac (complications)
  • Cholesterol, HDL (blood)
  • Docosahexaenoic Acids (therapeutic use)
  • Double-Blind Method
  • Drug Combinations
  • Eicosapentaenoic Acid (therapeutic use)
  • Female
  • Fish Oils (therapeutic use)
  • Follow-Up Studies
  • Heart (drug effects)
  • Humans
  • Hypertrophy, Left Ventricular (complications)
  • India
  • Lipid Peroxidation (drug effects)
  • Lipoproteins (blood)
  • Male
  • Middle Aged
  • Mustard Plant
  • Myocardial Infarction (complications, drug therapy, mortality)
  • Myocardium (enzymology)
  • Oxidative Stress
  • Plant Extracts (therapeutic use)
  • Plant Oils
  • Plants, Medicinal
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: